305 related articles for article (PubMed ID: 25170105)
1. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.
Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ
J Infect Dis; 2015 Feb; 211(4):529-38. PubMed ID: 25170105
[TBL] [Abstract][Full Text] [Related]
2. Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
Madhavi V; Kulkarni A; Shete A; Lee WS; Mclean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ;
J Acquir Immune Defic Syndr; 2017 Jul; 75(3):345-353. PubMed ID: 28346319
[TBL] [Abstract][Full Text] [Related]
3. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
[TBL] [Abstract][Full Text] [Related]
4. Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children.
Kumar S; Batra H; Singh S; Chawla H; Singh R; Katpara S; Hussain AW; Das BK; Lodha R; Kabra SK; Luthra K
J Gen Virol; 2020 Dec; 101(12):1289-1299. PubMed ID: 32915123
[TBL] [Abstract][Full Text] [Related]
5. HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).
Jensen SS; Fomsgaard A; Borggren M; Tingstedt JL; Gerstoft J; Kronborg G; Rasmussen LD; Pedersen C; Karlsson I
PLoS One; 2015; 10(12):e0145249. PubMed ID: 26696395
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC.
Worley MJ; Fei K; Lopez-Denman AJ; Kelleher AD; Kent SJ; Chung AW
J Immunol Methods; 2018 Jun; 457():41-52. PubMed ID: 29605231
[TBL] [Abstract][Full Text] [Related]
7. Activation of NK cells by ADCC antibodies and HIV disease progression.
Chung AW; Navis M; Isitman G; Wren L; Silvers J; Amin J; Kent SJ; Stratov I
J Acquir Immune Defic Syndr; 2011 Oct; 58(2):127-31. PubMed ID: 21792067
[TBL] [Abstract][Full Text] [Related]
8. The Early Antibody-Dependent Cell-Mediated Cytotoxicity Response Is Associated With Lower Viral Set Point in Individuals With Primary HIV Infection.
Chen X; Lin M; Qian S; Zhang Z; Fu Y; Xu J; Han X; Ding H; Dong T; Shang H; Jiang Y
Front Immunol; 2018; 9():2322. PubMed ID: 30356637
[TBL] [Abstract][Full Text] [Related]
9. Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count.
Forthal DN; Landucci G; Keenan B
AIDS Res Hum Retroviruses; 2001 Apr; 17(6):553-61. PubMed ID: 11350669
[TBL] [Abstract][Full Text] [Related]
10. Rapid degranulation of NK cells following activation by HIV-specific antibodies.
Chung AW; Rollman E; Center RJ; Kent SJ; Stratov I
J Immunol; 2009 Jan; 182(2):1202-10. PubMed ID: 19124764
[TBL] [Abstract][Full Text] [Related]
11. Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation.
Lichtfuss GF; Cheng WJ; Farsakoglu Y; Paukovics G; Rajasuriar R; Velayudham P; Kramski M; Hearps AC; Cameron PU; Lewin SR; Crowe SM; Jaworowski A
J Immunol; 2012 Aug; 189(3):1491-9. PubMed ID: 22745371
[TBL] [Abstract][Full Text] [Related]
12. Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design.
Madhavi V; Wren LH; Center RJ; Gonelli C; Winnall WR; Parsons MS; Kramski M; Kent SJ; Stratov I
AIDS; 2014 Aug; 28(13):1859-70. PubMed ID: 24937308
[TBL] [Abstract][Full Text] [Related]
13. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.
Ahmad A; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.
Madhavi V; Wines BD; Amin J; Emery S; ; Lopez E; Kelleher A; ; Center RJ; Hogarth PM; Chung AW; Kent SJ; Stratov I
J Virol; 2017 Sep; 91(18):. PubMed ID: 28701393
[TBL] [Abstract][Full Text] [Related]
15. Anti-HIV-1 antibody-dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum IgG.
Kramski M; Lichtfuss GF; Navis M; Isitman G; Wren L; Rawlin G; Center RJ; Jaworowski A; Kent SJ; Purcell DF
Eur J Immunol; 2012 Oct; 42(10):2771-81. PubMed ID: 22730083
[TBL] [Abstract][Full Text] [Related]
16. HIV-specific antibody-dependent phagocytosis matures during HIV infection.
Ana-Sosa-Batiz F; Johnston AP; Liu H; Center RJ; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Kaewkungwal J; Kim JH; Michael NL; Kelleher AD; Stratov I; Kent SJ; Kramski M
Immunol Cell Biol; 2014 Sep; 92(8):679-87. PubMed ID: 24913323
[TBL] [Abstract][Full Text] [Related]
17. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir.
Suryawanshi P; Bagul R; Shete A; Thakar M
Front Immunol; 2021; 12():663919. PubMed ID: 33995393
[TBL] [Abstract][Full Text] [Related]
19. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
[TBL] [Abstract][Full Text] [Related]
20. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
Lee WS; Prévost J; Richard J; van der Sluis RM; Lewin SR; Pazgier M; Finzi A; Parsons MS; Kent SJ
J Virol; 2019 May; 93(10):. PubMed ID: 30842324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
